Article
Insulin resistance predicts rapid virologic response to peginterferon/ribavirin combination therapy in hepatitis C genotype 4 patients.
The American journal of gastroenterology - 1 Sept 2010
Khattab Mahmoud, Eslam Mohammed, Sharwae Mohammed Ahmed, Shatat Mohammed, Ali Ahmed, Hamdy Lamia
Abstract excerpt
OBJECTIVES: In patients with chronic hepatitis C (CHC) of genotype 4, the predictors of rapid virologic response (RVR) have not been determined adequately. We aimed to assess which pretreatment variables might predict an RVR and a sustained virologic response (SVR). METHODS: A total of 131 non-diabetic, genotype 4 CHC patients were enrolled for analysis and treated with peginterferon-alpha-2b/ribavirin. Insulin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
